AMED, JPMA Discussing Joint Use of Compounds, with Policy Announcement Expected in Early June: Dr Suematsu of AMED

AMED President Makoto Suematsu The Japan Agency for Medical Research and Development (AMED) and the Japan Pharmaceutical Manufacturers Association (JPMA) appear to be continuing their behind-the-scenes discussions on joint drug discovery research using company compounds. Makoto Suematsu, president of AMED,...read more